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Irish public opinion on assisted human reproduction 
services: Contemporary assessments from a national 
sample
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4Department of Reproductive Endocrinology & Infertility, HRC-Fertility/Orange County, Newport Beach, CA, USA; 5Centre for Statistics in Medicine, 
Wolfson College Annexe, University of Oxford, Oxford, UK
Objective: To measure Irish opinion on a range of assisted human reproduction (AHR) treatments. 
Methods: A nationally representative sample of Irish adults (n = 1,003) were anonymously sampled by telephone survey. 
Results: Most participants (77%) agreed that any fertility services offered internationally should also be available in Ireland, although only a 
small minority of the general Irish population had personal familiarity with AHR or infertility. This sample finds substantial agreement (63%) 
that the Government of Ireland should introduce legislation covering AHR. The range of support for gamete donation in Ireland ranged from 
53% to 83%, depending on how donor privacy and disclosure policies are presented. For example, donation where the donor agrees to be con-
tacted by the child born following donation, and anonymous donation where donor privacy is completely protected by law were supported by 
68% and 66%, respectively. The least popular (53%) donor gamete treatment type appeared to be donation where the donor consents to be 
involved in the future life of any child born as a result of donor fertility treatment. Respondents in social class ABC1 (58%), age 18 to 24 (62%), 
age 25 to 34 (60%), or without children (61%) were more likely to favour this donor treatment policy in our sample. 
Conclusion: This is the first nationwide assessment of Irish public opinion on the advanced reproductive technologies since 2005. Access to a 
wide range of AHR treatment was supported by all subgroups studied. Public opinion concerning specific types of AHR treatment varied, yet 
general support for the need for national AHR legislation was reported by 63% of this national sample. Contemporary views on AHR remain 
largely consistent with the Commission for Assisted Human Reproduction recommendations from 2005, although further research is needed 
to clarify exactly how popular opinion on these issues has changed. It appears that legislation allowing for the full range of donation options 
(and not mandating disclosure of donor identity at a stipulated age) would better align with current Irish public opinion.
Keywords: Assisted fertility; Legislation; Public policy; In vitro fertilization; Ireland
Introduction
Reflecting the trend observed in other European countries, there 
has been a steady increase in IVF provision in Ireland in recent years 
[1,2]. Perhaps because IVF was initially undertaken by a limited num-
ber of Irish patients, having a statutory framework addressing assist-
ed human reproduction (AHR) treatments in Ireland was not an im-
mediate priority among national health policy goals. The need for 
Irish governmental oversight and a comprehensive legislative struc-
ture regarding AHR was formally recognised in 2001 with the estab-
lishment of the Commission for Assisted Human Reproduction (CAHR). 
This expert panel was charged with exploring possible regulatory 
approaches for assisted fertility treatment in Ireland. More specifically 
the CAHR Terms of Reference included publishing “a report on the 
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possible approaches to the regulation of all aspects of AHR and the 
social, ethical and legal factors to be taken into account in determin-
ing public policy and in this area.” The 151-page CAHR report was re-
leased in 2005 [3]. 
Of note, the Commission’s first recommendation was a call for a 
regulatory body to be “established by an Act of the Oireachtas to reg-
ulate AHR services in Ireland”. Such an agency would advise govern-
ment on all matters concerning AHR and associated procedures in-
cluding research in Ireland. Yet, since the CAHR report was published 
in 2005 there has been no progress towards legislation—although 
the topic does still occasionally receive attention during parliamenta-
ry debate [4]. Some legislators are mindful of this regulatory void, 
and acting Seanad leader Ivana Bacik regretted that questions about 
AHR in Ireland had to be confronted on a case-by-case basis (i.e., by 
judicial channels): “Indeed, it’s unfair on couples, on parents and on 
families to have to take litigation. Many of us have been saying this 
for years. We need legislation on IVF, on assisted human reproduction 
and on surrogacy” [5].
Having no AHR legislation in Ireland means that the only guidance 
medical practitioners have concerning clinical assisted fertility comes 
from the Irish Medical Council, in the form of its Guide to Professional 
Conduct & Ethics for Registered Medical Practitioners. This guidance on 
AHR from the Medical Council has undergone considerable change 
in recent years and these policy modifications occurred during a time 
when the composition of the Council was also reconfigured [6]. The 
present study sought to reappraise Irish public opinion on AHR, to 
assess any changes in public opinion compared to nearly a decade 
previously.
Methods
A multidisciplinary team of physicians, nurses, and demographers 
developed a brief questionnaire (validated externally by a private 
polling firm) to measure public opinion on multiple aspects of AHR. 
Unlike the CAHR study, this research was funded from our clinic bud-
get and received no government support. Data were obtained by 
landline and mobile telephone, using random digit dial methodology 
whereby all households in Ireland (including unlisted numbers) re-
mained eligible for sampling. Interviews were anonymous and no 
personally identifiable information was collected to ensure respon-
dent confidentiality (no in-person contact was made). Each respon-
dent was sampled only once; all polling was conducted in March 2013. 
Data were tabulated by professional canvassing staff (Red C Market-
ing & Research Ltd., Dublin, Ireland) using a computer aided telephone 
interviewing (CATI) modality. The CATI approach has a documented 
non-response rate of about 6% as validated by prior electoral and so-
cial queries, and this sampling technique produces some of the most 
accurate polls in Ireland. For example, during the 2011 campaign for 
the President of Ireland a national sample of about 1,000 predicted 
the election outcome to within 0.7% of the final ballot tally [7,8]. 
The following demographic parameters were queried: age, gender, 
geographic location, socioeconomic status, whether or not the re-
spondent had any children (and if yes, how many), and whether or 
not the respondent had experience with AHR treatment (or had con-
templated seeking such treatment). Next, respondents were asked 
the following questions: “With regard to fertility treatments such as 
IVF, do you agree or disagree that the government should pass legis-
lation to deal with these treatments in Ireland? Do you agree or dis-
agree that any fertility services now available internationally should 
also be available in Ireland? Would you be in favour or against allow-
ing these services in Ireland: IVF, sperm donation, egg donation, em-
bryo donation, pre-implantation genetic diagnosis, or embryo sex-
selection during IVF? Thinking about if the government were to make 
laws regarding egg and sperm donation, please give your opinion on 
how the anonymity of the donor should be addressed: donation 
where the donor consents to being involved in the future life of any 
child born from that donation, donation where the donor agrees to 
be contacted by any child born of any donation, identifiable donation 
where the donor agrees to have their identity made available to the 
child after he/she reaches 18 years of age, or anonymous donation 
where the law completely protects the privacy of the donor. If egg 
and sperm donation were to be legislated for in Ireland, it has been 
suggested that anonymous donation would be banned and any child 
conceived from egg or sperm donation would have a right to know 
who the donor was. To what extent do you support this suggestion?”
Responses were tabulated on a five-point Likert scale, ranging from 
1, strongly oppose; 2, slightly oppose; 3, neutral/no opinion; 4, slight-
ly favour; and 5, strongly favour.
Mathematical models were used to define quotas allowing equal 
survey input on the basis of age, gender, socioeconomic class, and 
geographical region. The sampling methodology statistically captures 
a representative sample of 98% of the adult Irish population (i.e., age 
≥18). Modified National Readership Survey definitions were used for 
class designation, as follows: A, upper middle class (higher manageri-
al, administrative, or professional); B, middle class (intermediate man-
agerial, administrative, or professional); C1, lower middle class (super-
visory or clerical, junior managerial, administrative or professional); 
C2, skilled working class (skilled manual workers); D, working class 
(semi-skilled & unskilled manual workers); E, those at lowest level of 
subsistence (pensioners, widows, casual or lowest grade workers); 
and F, unemployed [9]. The project was submitted to an independent 
ethics board, but because this was a survey of the general population 
and because no identifiable clinical data were recorded, the research 
was classified as exempt from review. 
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Results
The questionnaire was completed by 1,003 individuals between 
18th–20th March 2013; 49% were female and 51% were male (age 
range, 18 to “65 or over”). A social status of either A, B, or C1 was re-
ported by 41% of individuals, while 59% were either C2, D, E or F. Of 
the 37% sample with no children, 42% were male and 44% were res-
ident in Dublin. The average number of children in the overall sample 
population was 1.84. Of the 6% with infertility experience, only half 
(3%) had undertaken therapy with the remainder (3%) having re-
searched (but not initiated) treatment.
Agreement was high that, in principle, any fertility services offered 
in other countries should also be available in Ireland. Support for this 
did vary as a function of specific AHR intervention, as shown in Fig-
ure 1. Age, gender, child status, social class, and geographic distribu-
tion among those favouring each type of AHR treatment in Ireland 
are presented in Tables 1, 2. Regarding donor gamete treatment in 
Ireland, 80% favoured treatment involving identifiable donation 
(where the donor agrees to have their identity made known to the 
child after s/he reaches age 18). Subgroup analysis showed support 
Figure 1. Summary of public support in Ireland (%) for various modes 
of assisted fertility treatments as recorded from 1,003 respondents. 
Five-point Likert-scale responses are sorted by colour, where 1, strong-
ly favour (blue, upper band); 2, somewhat favour (sky blue); 3, neutral 
(green); 4, somewhat oppose (orange); and 5, strongly oppose (red, 
lower band). Mean Likert score for each treatment is given above each 
column. Percent data do not total to 100 due to patients with “don’t 
know” responses. IVF, in vitro fertilization; OD, oocyte donation; SD, 
sperm donation; SUR, surrogacy; ED, embryo donation; PGD, preim-
plantation genetic diagnosis; PGD/SS, embryo testing (PGD) for elec-
tive sex selection.
4.36 3.91 3.88 3.51 3.48 3.46 2.24
 IVF OD SD SUR ED PGD PGD/SS
Public opinion (% of sample)
37
15
21
8
16
37
14
21
10
15
34
11
23
8
15
15
6
17
10
50
49
16
17
5
11
50
14
18
6
10
68
12
102 6
Table 1. Gender, age, and child status among Irish study participants responding favourably to various AHR treatment types
Total
Gender Age (yr) Have any children?
Male Female 18-24 25-34 35-44 45-54 55-64 65+ No Yes
IVF 81 73 88 79 83 85 85 82 67 80 81
SD 65 62 67 69 75 73 64 57 44 71 61
OD 64 62 66 69 72 75 62 55 45 70 61
SUR 52 51 53 58 67 57 50 43 31 65 44
ED 51 53 49 56 64 57 46 43 33 60 45
PGD 46 43 49 47 47 50 45 47 39 47 45
PGD/SS 21 22 19 29 20 23 19 19 15 25 18
All data shown as % (n = 1,003). For this tabulation, favourable responses were aggregated from ‘slightly favour’ plus ‘strongly favour’. 
AHR, assisted human reproduction; IVF, in vitro fertilization; SD, sperm donation; OD, oocyte donation; SUR, surrogacy; ED, embryo donation; PGD, preimplanta-
tion genetic diagnosis; PGD/SS, PGD for elective embryo sex selection. 
Table 2. Social group status and geographic distribution among Irish study participants responding favourably to various AHR treatment types
Social group Province/Geographic region Setting
H L Dublin Leinster (outside Dublin) Munster Connaught/Ulster Urban Rural
IVF 86 79 81 81 78 83 82 79
SD 70 62 66 68 61 64 68 63
OD 69 62 66 70 60 59 67 62
SUR 58 50 54 55 53 43 57 47
ED 53 51 51 53 52 46 53 49
PGD 43 48 46 48 44 44 44 48
PGD/SS 19 23 21 21 22 19 21 22
All data shown as % (n = 1,003). For this tabulation, H & L Social group were defined as MRS classification ABC1 & C2DEF, respectively. Favourable responses 
were aggregated from ‘slightly favour’ plus ‘strongly favour’. 
AHR, assisted human reproduction; H, higher; L, lower; IVF, in vitro fertilization; SD, sperm donation; OD, oocyte donation; SUR, surrogacy; ED, embryo donation; 
PGD, preimplantation genetic diagnosis; PGD/SS, PGD for elective embryo sex selection; MRS, Market Research Society.
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for this policy to be highest among those respondents aged 18 to 24, 
and among those with no children. Donation where the donor agrees 
to be contacted by the child born following donation, and anony-
mous donation where donor privacy is completely protected by law 
were supported by 68% and 66%, respectively. The least popular 
(53%) donor gamete treatment type appeared to be donation where 
the donor consents to be involved in the future life of any child born 
as a result of donor fertility treatment. Respondents in social class 
ABC1 (58%), age 18 to 24 (62%), age 25 to 34 (60%), or without chil-
dren (61%) were more likely to favour this donor treatment policy in 
this sample. Concerning the need for legislation covering fertility ser-
vices in Ireland, most (79%) respondents favoured government in-
volvement (Figure 2).
Discussion
The lack of Irish legislation on AHR has become more problematic 
as the number of patients seeking fertility treatments in Ireland has 
increased, resulting in an intractable health policy puzzle of expand-
ing dimensions [10-12]. Recent research has explored selected as-
pects of AHR in Ireland including compensation for IVF gamete do-
nors and their privacy [13], embryo disposition [14] and abandon-
ment of IVF embryos in Ireland [15]. While these reports did yield 
original information, the findings were limited because they were 
based on data derived only from individuals already seeking medical 
fertility consultation. The present study brings questions concerning 
AHR before a national Irish audience, and is the first such sampling 
undertaken without government sponsorship or oversight.
Our survey data show that 94% of the general Irish population has 
no personal experience with any medical fertility therapy. Neverthe-
less, public support for IVF remained above 50% even among indi-
viduals age 65 or older. This is a previously unreported observation; it 
suggests a willingness by Irish senior citizens to support a class of 
treatment which the respondents themselves would not seek per-
sonally. It would be reasonable to expect an even higher level of sup-
port for AHR interventions if our investigation had been confined 
only to the subset of Irish adults with direct infertility experience, and 
this represents the focus of additional research.
Donor gametes in assisted fertility treatment have long been a 
source of debate, particularly on the matter of privacy and confiden-
tiality, and there is no consensus among policy experts and ethicists 
as to what represents the best way forward [16,17]. The relevance of 
donor oocyte policy in Ireland thus far has been limited, because just 
one Irish IVF unit provides this service [18]. This investigation shows 
mixed public opinion on oocyte donation in Ireland, with most re-
spondents favouring identifiable donation. In this sample, public 
support was lowest for AHR treatments where the gamete donor 
was allowed to be involved in the life of the offspring. This finding 
generally aligns with previously published questionnaire data col-
lected in Dublin from IVF patients themselves [19].
From these data, most respondents (77%) appear to agree in prin-
ciple that any fertility treatment offered internationally should also 
be available within Ireland. IVF is the best known of the advanced re-
productive technologies, and it was viewed positively by most of the 
Irish public sampled. However, we registered progressively reduced 
public support of sperm donation, oocyte donation, and embryo do-
nation, surrogacy, pre-implantation genetic diagnosis (PGD) and em-
bryo sex-selection in Ireland. While our research did identify broad 
public support for most types of AHR treatment in Ireland, embryo 
sex-selection was the exceptional case, with half of the sample ex-
pressing a strongly negative opinion of this particular fertility service.
 Our study has several potential limitations which should be consid-
ered. Although sampling adequacy can be a concern in any national 
survey, the statistical model used by an experienced polling group is 
regarded as robust. Unfortunately, it was not possible to make matched 
comparisons to the original CAHR assessments because the Commis-
sion did not publish raw polling data from 2001 to 2005. There is also 
the fundamental question of how well complex AHR treatments are 
actually understood in the general community (where most have no 
direct experience with infertility or its possible treatments). Particu-
larly for PGD, even among some physicians the knowledge level of 
advanced genetic tests can be low [20]. However, because these data 
were gathered by professional staff experienced in sampling Irish 
public opinion on other complex and sensitive topics (i.e., abortion, 
education funding, immigration, tax policy, etc.), we believe our re-
Slightly and strongly disagree  10% Don’t know  1%
63%
Agree strongly
16%
Agree slightly
10%
Neutral
3% 7%
Figure 2. Distribution of Irish public opinion in 2013 regarding the 
need for national assisted human reproduction legislation. Among 
those who responded affirmatively (79%), females comprised 83%, 
Dublin residents comprised 84% and those with direct fertility expe-
rience accounted for 85%. Among those opposing legislation (10%), 
those who disagreed that any fertility services available internation-
ally should also be available in Ireland comprised 52%.
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sults involve very little bias.
In conclusion, results from this contemporary national sample pro-
vide new evidence that most Irish citizens support this government 
in legislating for IVF and allied treatments. IVF is not currently provid-
ed by the Irish public health service, nor was this benefit available in 
the past. Most respondents will never require AHR treatment them-
selves but still appear to support clinics in Ireland offering the same 
assisted fertility treatments that are available internationally. These 
views remain largely consistent with the CAHR recommendations 
from 2005. Only on matters of embryo sex-selection and gamete do-
nor privacy were specific CAHR recommendations found lacking in 
current support, although further research is needed to clarify exactly 
how popular opinion on these issues has changed. It appears that 
legislation allowing for the full range of donation options (and not 
mandating disclosure of donor identity at a stipulated age) would 
better align with contemporary Irish public opinion. Although our 
data show the population of Ireland does not support PGD for elec-
tive sex-selection, it is possible that the application of this technology 
with IVF would be accepted if limited to the prevention of serious 
sex-linked genetic conditions. These issues represent the focus of on-
going research at our institutions to better inform the wider public 
discourse on AHR regulation in Ireland.
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